Renalytix Market Cap

Renalytix has a market cap or net worth of $35.47 million as of April 29, 2025. Its market cap has decreased by -27.09% in one year.

Market Cap

35.47M

Enterprise Value

33.96M

Revenue

2.89M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.24

Market Cap Chart

Since November 6, 2018, Renalytix's market cap has decreased from 84.47M to 35.47M, a decrease of -58.00%. That is a compound annual growth rate of -12.53%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2025	35.47M	-20.41%
Dec 31, 2024	44.57M	125.93%
Dec 29, 2023	19.73M	-69.84%
Dec 30, 2022	65.42M	-89.22%
Dec 31, 2021	607.05M	26.62%
Dec 31, 2020	479.42M	67.37%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Nika Pharmaceuticals	1.02B
Veradigm	743.17M
Glass House Brands	483.81M
Elite Pharmaceuticals	443.14M
Northwest Biotherapeutics	402.45M
CytoDyn	288.39M
BioStem Technologies	244.71M

Market Cap Rankings